These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 32237110)

  • 1. Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry.
    Kapelios CJ; Laroche C; Crespo-Leiro MG; Anker SD; Coats AJS; Díaz-Molina B; Filippatos G; Lainscak M; Maggioni AP; McDonagh T; Mebazaa A; Metra M; Moura B; Mullens W; Piepoli MF; Rosano GMC; Ruschitzka F; Seferovic PM; Lund LH;
    Eur J Heart Fail; 2020 Aug; 22(8):1424-1437. PubMed ID: 32237110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensification of pharmacological decongestion but not the actual daily loop diuretic dose predicts worse chronic heart failure outcome: insights from TIME-CHF.
    Simonavičius J; Maeder MT; Eurlings CGMJ; Aizpurua AB; Čelutkienė J; Barysienė J; Toggweiler S; Kaufmann BA; Brunner-La Rocca HP
    Clin Res Cardiol; 2021 Aug; 110(8):1221-1233. PubMed ID: 33216179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of short-acting vs. long-acting loop diuretics after heart failure hospitalization.
    Imaeda S; Shiraishi Y; Kohsaka S; Niimi N; Goda A; Nagatomo Y; Takei M; Saji M; Nakano S; Kohno T; Fukuda K; Yoshikawa T
    ESC Heart Fail; 2022 Oct; 9(5):2967-2977. PubMed ID: 35730147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between high-dose loop diuretic use at discharge and cardiovascular mortality in patients with heart failure.
    Okabe T; Yakushiji T; Kido T; Oyama Y; Igawa W; Ono M; Ebara S; Yamashita K; Yamamoto MH; Saito S; Amemiya K; Isomura N; Ochiai M
    ESC Heart Fail; 2018 Feb; 5(1):87-94. PubMed ID: 28967699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fraction.
    Ter Maaten JM; Martens P; Damman K; Dickstein K; Ponikowski P; Lang CC; Ng LL; Anker SD; Samani NJ; Filippatos G; Cleland JG; Zannad F; Hillege HL; van Veldhuisen DJ; Metra M; Voors AA; Mullens W
    Clin Res Cardiol; 2020 Aug; 109(8):1048-1059. PubMed ID: 32002631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diuretic therapy as prognostic enrichment factor for clinical trials in patients with heart failure with reduced ejection fraction.
    Coiro S; Girerd N; McMurray JJV; Pitt B; Swedberg K; van Veldhuisen DJ; Lamiral Z; Rossignol P; Zannad F
    Clin Res Cardiol; 2021 Aug; 110(8):1308-1320. PubMed ID: 33956209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of loop diuretics in patients with chronic heart failure: an observational overview.
    Scholte NT; Aydin D; Linssen GC; Koudstaal S; Rademaker PC; Geerlings PR; van Gent MW; Aksoy I; Oosterom L; Boersma E; Brunner-La Rocca HP; Brugts JJ
    Open Heart; 2023 Nov; 10(2):. PubMed ID: 38011993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loop diuretic use at discharge is associated with adverse outcomes in hospitalized patients with heart failure: a report from the Japanese cardiac registry of heart failure in cardiology (JCARE-CARD).
    Hamaguchi S; Kinugawa S; Tsuchihashi-Makaya M; Goto D; Yamada S; Yokoshiki H; Takeshita A; Tsutsui H;
    Circ J; 2012; 76(8):1920-7. PubMed ID: 22665070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous Diuretic Therapy for the Management of Heart Failure and Volume Overload in a Multidisciplinary Outpatient Unit.
    Buckley LF; Carter DM; Matta L; Cheng JW; Stevens C; Belenkiy RM; Burpee LJ; Young MA; Weiffenbach CS; Smallwood JA; Stevenson LW; Desai AS
    JACC Heart Fail; 2016 Jan; 4(1):1-8. PubMed ID: 26656139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure - A multicenter propensity score matched analysis.
    Täger T; Fröhlich H; Grundtvig M; Seiz M; Schellberg D; Goode K; Kazmi S; Hole T; Katus HA; Atar D; Cleland JGF; Agewall S; Clark AL; Frankenstein L
    Int J Cardiol; 2019 Aug; 289():83-90. PubMed ID: 30827731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose of furosemide before admission predicts diuretic efficiency and long-term prognosis in acute heart failure.
    Blázquez-Bermejo Z; Farré N; Caravaca Perez P; Llagostera M; Morán-Fernández L; Fort A; de Juan Bagudá J; García-Cosio MD; Ruiz-Bustillo S; Delgado JF
    ESC Heart Fail; 2022 Feb; 9(1):656-666. PubMed ID: 34766460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications.
    Nuzzi V; Cannatà A; Pellicori P; Manca P; Stolfo D; Gregorio C; Barbati G; Bromage DI; McDonagh T; Cleland JGF; Merlo M; Sinagra G
    Clin Res Cardiol; 2023 Mar; 112(3):419-430. PubMed ID: 36385396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loop diuretic dose adjustments after a hospitalization for heart failure: insights from ASCEND-HF.
    DeVore AD; Hasselblad V; Mentz RJ; O'Connor CM; Armstrong PW; McMurray JJ; Ezekowitz JA; Tang WH; Starling RC; Voors AA; Califf RM; Hernandez AF
    Eur J Heart Fail; 2015 Mar; 17(3):340-6. PubMed ID: 25619549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loop diuretic adjustments in patients with chronic heart failure: Insights from HF-ACTION.
    Fudim M; O'Connor CM; Mulder H; Coles A; Bhatt AS; Ambrosy AP; Kraus WE; Piña IL; Whellan DJ; Mentz RJ
    Am Heart J; 2018 Nov; 205():133-141. PubMed ID: 30158057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outpatient diuretic intensification as endpoint in heart failure with preserved ejection fraction trials: an analysis from TOPCAT.
    Ferreira JP; Liu J; Claggett BL; Vardeny O; Pitt B; Pfeffer MA; Solomon SD; Zannad F
    Eur J Heart Fail; 2022 Feb; 24(2):378-384. PubMed ID: 34755426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diuretic Changes, Health Care Resource Utilization, and Clinical Outcomes for Heart Failure With Reduced Ejection Fraction: From the Change the Management of Patients With Heart Failure Registry.
    Khan MS; Greene SJ; Hellkamp AS; DeVore AD; Shen X; Albert NM; Patterson JH; Spertus JA; Thomas LE; Williams FB; Hernandez AF; Fonarow GC; Butler J
    Circ Heart Fail; 2021 Nov; 14(11):e008351. PubMed ID: 34674536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contemporary Drug Treatment of Chronic Heart Failure With Reduced Ejection Fraction: The CHECK-HF Registry.
    Brunner-La Rocca HP; Linssen GC; Smeele FJ; van Drimmelen AA; Schaafsma HJ; Westendorp PH; Rademaker PC; van de Kamp HJ; Hoes AW; Brugts JJ;
    JACC Heart Fail; 2019 Jan; 7(1):13-21. PubMed ID: 30606482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loop diuretic down-titration at discharge in patients hospitalized for acute heart failure.
    Croset F; Llàcer P; Núñez J; Campos J; García M; Pérez A; Fernández C; Fabregate M; López G; Tello S; Fernández JM; Ruiz R; Manzano L
    ESC Heart Fail; 2024 Jun; 11(3):1739-1747. PubMed ID: 38454739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction.
    Damman K; Kjekshus J; Wikstrand J; Cleland JG; Komajda M; Wedel H; Waagstein F; McMurray JJ
    Eur J Heart Fail; 2016 Mar; 18(3):328-36. PubMed ID: 26693947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and long-term outcome in outpatients with chronic heart failure in Northwestern Europe.
    Fröhlich H; Rosenfeld N; Täger T; Goode K; Kazmi S; Hole T; Katus HA; Atar D; Cleland JGF; Agewall S; Clark AL; Frankenstein L; Grundtvig M
    Heart; 2019 Aug; 105(16):1252-1259. PubMed ID: 30792238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.